![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Chief Tech/Sci/R&D Officer at
KYMERA THERAPEUTICS, INC.
Net worth: 6 M $ as of 31/05/2026
Profile
Jared Gollob is Chief Medical Officer at Kymera Therapeutics, Inc. since 2018.
Formerly, Dr. Gollob was Director of the Biologic Therapy Program at Duke University from 2002 to 2007.
From 2012 to 2018, Dr. Gollob was Global VP of Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 71,359 ( 0.09% ) | 6 M $ | 31/05/2026 |
Jared Gollob active positions
| Companies | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
Former positions of Jared Gollob
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2007 |
Training of Jared Gollob
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
- Stock Market
- Insiders
- Jared Gollob
